Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)

Bibliographic Details
Main Authors: Riddle, Matthew C., Forst, Thomas, Aronson, Ronnie, Sauque-Reyna, Leobardo, Souhami, Elisabeth, Silvestre, Louise, Ping, Lin, Rosenstock, Julio
Format: Online
Language:English
Published: American Diabetes Association 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747901/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747901/

Similar Items